<DOC>
	<DOCNO>NCT01371708</DOCNO>
	<brief_summary>This 6-month , open-label , flexible-dose study evaluate Desvenlafaxine Succinate Sustained-Release ( DVS SR ) Treatment Child Adolescent Outpatients Major Depressive Disorder ( MDD ) .</brief_summary>
	<brief_title>A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety , Tolerability , And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Desvenlafaxine Succinate</mesh_term>
	<criteria>Completed study B2061032 investigator 's opinion , would benefit long term treatment DVS SR Willingness ability comply schedule visit , treatment plan , procedures Requires precaution suicide Not generally healthy medical condition Poor compliance study drug study procedure participation study B2061032</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>MDD</keyword>
	<keyword>Depression</keyword>
</DOC>